SALIVARY CANCER
Clinical trials for SALIVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new SALIVARY CANCER trials appear
Sign up with your email to follow new studies for SALIVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy trial offers hope for advanced cancer patients out of options
Disease control OngoingThis study tested an immunotherapy drug called pembrolizumab in people with many different types of advanced solid tumors that had stopped responding to standard treatments. The main goal was to see if the drug could shrink tumors and to identify biological markers that might pre…
Matched conditions: SALIVARY CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for rare salivary cancers: repurposed drug enters trial
Disease control OngoingThis study is testing if the drug enzalutamide can shrink tumors in people with advanced salivary gland cancer that has a specific marker (androgen receptor). The trial will enroll about 46 patients to see if the treatment is effective and safe. Enzalutamide is already approved f…
Matched conditions: SALIVARY CANCER
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC